Arizona State Retirement System’s Phathom Pharmaceuticals PHAT Stock Holding History

Arizona State Retirement System’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$147K	Buy	13,589 +732	+6%	+$8.35K	﹤0.01%	2022
2026 Q1	$143K	Buy	12,857 +990	+8%	+$12.5K	﹤0.01%	1980
2025 Q4	$197K	Buy	+11,867	New	+$169K	﹤0.01%	1924
2025 Q2	–	Sell	-10,768	Closed	-$67.5K	–	2104
2025 Q1	$67.5K	Sell	10,768 -132	-1%	-$801	﹤0.01%	2068
2024 Q4	$88.5K	Buy	10,900 +86	+0.8%	+$1.06K	﹤0.01%	2099
2024 Q3	$196K	Buy	+10,814	New	+$151K	﹤0.01%	1975

Other funds holding PHAT

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Arizona State Retirement System's PHAT Position: Q2 2026 in Review

Arizona State Retirement System increased its Phathom Pharmaceuticals (PHAT) stake by 5.7% in Q2 2026, buying an estimated $8.35K and bringing the position to 13,589 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #2022.

Arizona State Retirement System first reported a position in PHAT in Q3 2024 and has held it in 6 quarters since. The position peaked at $197K in Q4 2025. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

Arizona State Retirement System held 13,589 shares of Phathom Pharmaceuticals worth $147K as of Q2 2026.
Arizona State Retirement System bought 732 Phathom Pharmaceuticals shares in Q2 2026, an estimated $8.35K.
Phathom Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #2022 holding.
Arizona State Retirement System first reported a position in Phathom Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
Arizona State Retirement System's Phathom Pharmaceuticals position peaked at $197K in Q4 2025.
162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.